Bioblast Pharma Reports Receipt Of Nasdaq Notification Related To Minimum Shareholders' Equity Non Compliance; Co. Has Until Feb. 22, 2019 To Submit Plan To Regain Compliance To Nasdaq
Benzinga Newsdesk